Literature DB >> 17540555

Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.

Pentti Tuohimaa1, Eero Pukkala, Ghislaine Scélo, Jorgen H Olsen, David H Brewster, Kari Hemminki, Elizabeth Tracey, Elisabete Weiderpass, Erich V Kliewer, Vera Pompe-Kirn, Mary L McBride, Carmen Martos, Kee-Seng Chia, Jon M Tonita, Jon G Jonasson, Paolo Boffetta, Paul Brennan.   

Abstract

BACKGROUND: Skin cancers are known to be associated with sun exposure, whereas sunlight through the production of vitamin D may protect against some cancers. The aim of this study was to assess whether patients with skin cancer have an altered risk of developing other cancers.
METHODS: The study cohort consisted of 416,134 cases of skin cancer and 3,776,501 cases of non-skin cancer as a first cancer extracted from 13 cancer registries. 10,886 melanoma and 35,620 non-melanoma skin cancer cases had second cancers. The observed numbers (O) of 46 types of second primary cancer after skin melanoma, basal cell carcinoma or non-basal cell carcinoma, and of skin cancers following non-skin cancers were compared to the expected numbers (E) derived from the age, sex and calendar period specific cancer incidence rates in each of the cancer registries (O/E=SIR, standardised incidence ratios). Rates from cancer registries classified to sunny countries (Australia, Singapore and Spain) and less sunny countries (Canada, Denmark, Finland, Iceland, Norway, Scotland, Slovenia and Sweden) were compared to each other.
RESULTS: SIR of all second solid primary cancers (except skin and lip) after skin melanoma were significantly lower for the sunny countries (SIR(S)=1.03; 95% CI 0.99-1.08) than in the less sunny countries (SIR(L)=1.14; 95%CI 1.11-1.17). The difference was more obvious after non-melanoma skin cancers: after basal cell carcinoma SIR(S)/SIR(L)=0.65 (95%CI=0.58-0.72); after non-basal cell carcinoma SIR(S)/SIR(L)=0.58 (95%CI=0.50-0.67). In sunny countries, the risk of second primary cancer after non-melanoma skin cancers was lower for most of the cancers except for lip, mouth and non-Hodgkin lymphoma.
CONCLUSIONS: Vitamin D production in the skin seems to decrease the risk of several solid cancers (especially stomach, colorectal, liver and gallbladder, pancreas, lung, female breast, prostate, bladder and kidney cancers). The apparently protective effect of sun exposure against second primary cancer is more pronounced after non-melanoma skin cancers than melanoma, which is consistent with earlier reports that non-melanoma skin cancers reflect cumulative sun exposure, whereas melanoma is more related to sunburn.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540555     DOI: 10.1016/j.ejca.2007.04.018

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  35 in total

1.  Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers.

Authors:  William B Grant; Johan E Moan; Emanuela Micu; Alina C Porojnicu; Asta Juzeniene
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Duration of vitamin D synthesis from weather model data for use in prospective epidemiological studies.

Authors:  Kåre Edvardsen; Ola Engelsen; Magritt Brustad
Journal:  Int J Biometeorol       Date:  2009-05-15       Impact factor: 3.787

3.  Heterogeneity in the Strehler-Mildvan general theory of mortality and aging.

Authors:  Hui Zheng; Yang Yang; Kenneth C Land
Journal:  Demography       Date:  2011-02

4.  Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers?

Authors:  Anthony J Alberg; Alexander H Fischer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

Review 5.  Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review.

Authors:  Lee Wheless; Joshua Black; Anthony J Alberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

6.  Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2011-07-01

7.  Parathormone and 1,25(OH)2D3 but not 25(OH)D3 serum levels, in an inverse correlation, reveal an association with advanced stages of colorectal cancer.

Authors:  Anestis Charalampopoulos; Alexander Charalabopoulos; Anna Batistatou; Christos Golias; Antonia Anogeianaki; Dimitrios Peschos; Iosif Iliadis; Anastasios Macheras; Konstantinos Charalabopoulos
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

8.  Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Christian C Abnet; Yu Chen; Wong-Ho Chow; Yu-Tang Gao; Kathy J Helzlsouer; Loïc Le Marchand; Marjorie L McCullough; James M Shikany; Jarmo Virtamo; Stephanie J Weinstein; Yong-Bing Xiang; Kai Yu; Wei Zheng; Demetrius Albanes; Alan A Arslan; David S Campbell; Peter T Campbell; Richard B Hayes; Ronald L Horst; Laurence N Kolonel; Abraham M Y Nomura; Mark P Purdue; Kirk Snyder; Xiao-Ou Shu
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

9.  Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Rachael Z Stolzenberg-Solomon; Eric J Jacobs; Alan A Arslan; Dai Qi; Alpa V Patel; Kathy J Helzlsouer; Stephanie J Weinstein; Marjorie L McCullough; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Jarmo Virtamo; Lynn R Wilkins; Kai Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Demetrius Albanes; Qiuyin Cai; Chinonye Harvey; Richard Hayes; Sandra Clipp; Ronald L Horst; Lonn Irish; Karen Koenig; Loic Le Marchand; Laurence N Kolonel
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

10.  Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.

Authors:  Rachael Z Stolzenberg-Solomon; Richard B Hayes; Ron L Horst; Kristin E Anderson; Bruce W Hollis; Debra T Silverman
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.